CODEXIS, INC. (CDXS)

Sentiment-Signal

24,6
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
16.06.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEChis description is incorporated by reference into Item 5.02 of this Current Report on Form 8-K. The above and the incorp

Stammdaten

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Unternehmen & Branche

NameCODEXIS, INC.
TickerCDXS
CIK0001200375
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2860 · Industrial Organic Chemicals

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung253,1 Mio. USD
Beta2,08
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K70,387,000-43,974,000-0.50147,797,00050,529,000
2025-09-3010-Q8,601,000-19,615,000-0.22123,961,00038,544,000
2025-06-3010-Q15,328,000-13,272,000-0.16138,246,00055,631,000
2025-03-3110-Q7,543,000-20,688,000-0.25128,887,00049,629,000
2024-12-3110-K59,345,000-65,276,000-0.89149,011,00066,927,000
2024-09-3010-Q12,833,000-20,640,000-0.29148,183,00073,400,000
2024-06-3010-Q7,979,000-22,755,000-0.32132,006,00061,447,000
2024-03-3110-Q17,073,000-11,505,000-0.16149,559,00079,267,000
2023-12-3110-K70,143,000-76,240,000-1.12136,561,00086,615,000
2023-09-3010-Q9,277,000-34,908,000-0.50154,455,00091,506,000
2023-06-3010-Q21,323,000-11,523,000-0.17206,761,000124,131,000
2023-03-3110-Q12,982,000-22,617,000-0.34218,068,000126,016,000
2022-12-3110-K138,590,000-33,592,000-0.51250,393,000144,797,000
2022-09-3010-Q34,470,000-9,992,000-0.15235,288,000154,131,000
2022-06-3010-Q38,406,000-2,640,000-0.04234,970,000159,459,000
2022-03-3110-Q35,340,000-8,356,000-0.13235,274,000158,635,000
2021-12-3110-K104,754,000-21,279,000-0.33246,383,000164,391,000
2021-09-3010-Q36,769,0002,244,0000.03227,551,000169,055,000
2021-06-3010-Q25,453,000-4,265,000-0.07212,310,000162,773,000
2021-03-3110-Q18,032,000-9,068,000-0.14212,170,000163,739,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-02-24Lutz StefanOfficer, Chief Scientific OfficerOpen Market Sale-5,8621.13-6,641.06-2,2%
2026-02-06Erbez GeorgiaOfficer, See RemarksOpen Market Sale-3,8261.31-5,000.96-1,7%
2026-02-06Lutz StefanOfficer, Chief Scientific OfficerOpen Market Sale-2,4921.31-3,257.29-1,1%
2026-02-06MOORE ALISONDirector, Officer, President and CEOOpen Market Sale-3,8261.31-5,000.96-1,7%
2026-01-07Lutz StefanOfficer, CSOOpen Market Sale-4,6851.70-7,949.51-2,7%
2025-12-01Opaleye Management Inc.10% OwnerOpen Market Sale-245,0001.67-408,537.50-137,1%
2025-12-01Opaleye Management Inc.10% OwnerOpen Market Sale-245,0001.67-408,537.50-137,1%
2025-12-01Opaleye Management Inc.10% OwnerOpen Market Sale-8,5331.67-14,228.78-4,8%
2025-12-01Opaleye Management Inc.10% OwnerOpen Market Sale-8,5331.67-14,228.78-4,8%
2025-11-28Opaleye Management Inc.10% OwnerOpen Market Sale-2,4901.75-4,357.50-1,5%
2025-11-28Opaleye Management Inc.10% OwnerOpen Market Sale-2,4901.75-4,357.50-1,5%
2025-11-28Opaleye Management Inc.10% OwnerOpen Market Sale-105,0001.75-183,750.00-61,7%
2025-11-28Opaleye Management Inc.10% OwnerOpen Market Sale-105,0001.75-183,750.00-61,7%
2025-11-26Opaleye Management Inc.10% OwnerOpen Market Sale-5,0001.74-8,706.50-2,9%
2025-11-26Opaleye Management Inc.10% OwnerOpen Market Sale-148,3181.74-258,266.13-86,7%
2025-11-26Opaleye Management Inc.10% OwnerOpen Market Sale-5,0001.74-8,706.50-2,9%
2025-11-26Opaleye Management Inc.10% OwnerOpen Market Sale-148,3181.74-258,266.13-86,7%
2025-11-21WOLF DENNIS PDirectorOpen Market Sale-8,9521.56-13,988.40-4,7%
2025-11-12Opaleye Management Inc.10% OwnerOpen Market Sale-890,0001.94-1,724,108.00-578,8%
2025-11-12Opaleye Management Inc.10% OwnerOpen Market Sale-27,4591.94-53,193.57-17,9%
2025-11-12Opaleye Management Inc.10% OwnerOpen Market Sale-165,0001.96-323,730.00-108,7%
2025-11-11De Vre RaymondDirectorOpen Market Sale-1,4131.74-2,458.62-0,8%
2025-11-11Opaleye Management Inc.10% OwnerOpen Market Sale-13,2111.80-23,771.87-8,0%
2025-11-11Opaleye Management Inc.10% OwnerOpen Market Sale-535,0001.80-962,679.00-323,2%
2025-11-11Opaleye Management Inc.10% OwnerOpen Market Sale-13,2111.80-23,771.87-8,0%
2025-11-11Opaleye Management Inc.10% OwnerOpen Market Sale-535,0001.80-962,679.00-323,2%
2025-11-10Opaleye Management Inc.10% OwnerOpen Market Sale-3,3181.73-5,755.73-1,9%
2025-11-10Opaleye Management Inc.10% OwnerOpen Market Sale-3,3181.73-5,755.73-1,9%
2025-11-10Opaleye Management Inc.10% OwnerOpen Market Sale-205,0001.73-355,613.50-119,4%
2025-11-10Opaleye Management Inc.10% OwnerOpen Market Sale-205,0001.73-355,613.50-119,4%
2025-11-07Opaleye Management Inc.10% OwnerOpen Market Sale-10,0001.70-16,968.00-5,7%
2025-11-07Opaleye Management Inc.10% OwnerOpen Market Sale-10,0001.70-16,968.00-5,7%
2025-11-07Opaleye Management Inc.10% OwnerOpen Market Sale-296,6821.70-503,410.02-169,0%
2025-11-07Opaleye Management Inc.10% OwnerOpen Market Sale-296,6821.70-503,410.02-169,0%
2025-10-13Erbez GeorgiaOfficer, Chief Financial OfficerOpen Market Sale-6,2392.51-15,628.70-5,2%
2025-10-13MOORE ALISONOfficer, Chief Technical OfficerOpen Market Sale-6,2392.51-15,629.32-5,2%
2025-08-04Opaleye Management Inc.10% OwnerOpen Market Purchase7802.842,211.30+0,7%
2025-07-31Opaleye Management Inc.10% OwnerOpen Market Purchase84,2202.68225,709.60+75,8%
2025-07-30Opaleye Management Inc.10% OwnerOpen Market Purchase1,5782.804,410.51+1,5%
2025-07-29Opaleye Management Inc.10% OwnerOpen Market Purchase8,4222.8223,750.04+8,0%
2025-07-18Opaleye Management Inc.10% OwnerOpen Market Purchase100,0002.82282,000.00+94,7%
2025-06-27Opaleye Management Inc.10% OwnerOpen Market Purchase100,0002.39239,000.00+80,2%
2025-06-16Opaleye Management Inc.10% OwnerOpen Market Purchase50,8982.24114,011.52+38,3%
2025-06-13Opaleye Management Inc.10% OwnerOpen Market Purchase99,1022.23220,997.46+74,2%
2025-06-12Opaleye Management Inc.10% OwnerOpen Market Purchase100,0002.25225,000.00+75,5%
2025-05-28Opaleye Management Inc.10% OwnerOpen Market Purchase5,0002.3611,800.00+4,0%
2025-05-23Opaleye Management Inc.10% OwnerOpen Market Purchase2,320,0002.365,475,200.00+1838,0%
2025-05-01Opaleye Management Inc.10% OwnerOpen Market Purchase20,0002.3246,436.00+15,6%
2025-04-30Opaleye Management Inc.10% OwnerOpen Market Purchase25,0002.3157,660.00+19,4%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×